The Effect of Liraglutide on Pancreatic Hormones and Its Size

NCT03520062 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml

Sponsor

Nicolai Jacob Wewer Albrechtsen

Collaborators

[object Object]
[object Object]